The drugmaker will provide fill and finish manufacturing capacity, which will take place at its facility in Ridgefield, N.J.
Sanofi has now committed to manufacturing all three COVID-19 vaccines authorized for emergency use in the U.S., as the drugmaker has also signed agreements to produce the vaccines designed by Pfizer and Johnson & Johnson.
More articles on pharmacy:
8 key COVID-19 vaccine administration errors
COVID-19 vaccine surplus rose by 30% in 2 weeks
US resumes use of J&J’s COVID-19 vaccine
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
